PMID- 24682420 OWN - NLM STAT- MEDLINE DCOM- 20141218 LR - 20140414 IS - 1791-244X (Electronic) IS - 1107-3756 (Linking) VI - 33 IP - 6 DP - 2014 Jun TI - Suppression of allergic and inflammatory responses by essential oils derived from herbal plants and citrus fruits. PG - 1643-51 LID - 10.3892/ijmm.2014.1720 [doi] AB - The aim of the present study was to investigate the biological activity of 20 essential oils (EOs) derived from herbal plants and citrus fruits. The in vitro anti-allergic and anti-inflammatory activities of these oils were investigated, and the EO which was found to have the strongest activity of the 20 EOs examined, was investigated further to identify its components and bioactive compounds. The in vitro anti-allergic activity was determined by measuring the release of beta-hexosaminidase from rat basophilic leukemia (RBL-2H3) cells treated with the calcium ionophore, A23187. The in vitro anti-inflammatory activity was determined by measuring the production of tumor necrosis factor-alpha (TNF-alpha) in RAW264.7 murine macrophages treated with lipopolysaccharide. Among the EOs examined, lemongrass [Cymbopogon citratus (DC.) Stapf] elicited the strongest anti-allergic and anti-inflammatory effects. A principal component of this EO is citral (3,7-dimethyl-2,6-octadien-1-al) (74.5%), a mixture of the stereoisomers, geranial (trans-citral, 40.16%) and neral (cis-citral, 34.24%), as determined by chromatography-mass spectrometry analysis. The activities of citral and geranial are similar to those of lemongrass EO. These compounds elicited significant in vivo anti-allergic and anti-inflammatory effects, suppressing an immunoglobulin E (IgE)-induced passive cutaneous anaphylactic reaction in mice and a 12-O-tetradecanoylphorbol-13-acetate-induced inflammatory mouse ear edema, respectively. Our data demonstrate that lemongrass EO and its constituents, citral and geranial, may be a therapeutic candidate for allergic and inflammatory diseases. FAU - Mitoshi, Mai AU - Mitoshi M AD - Laboratory of Food and Nutritional Sciences, Faculty of Nutrition, Kobe Gakuin University, Kobe, Hyogo 651‑2180, Japan. FAU - Kuriyama, Isoko AU - Kuriyama I AD - Laboratory of Food and Nutritional Sciences, Faculty of Nutrition, Kobe Gakuin University, Kobe, Hyogo 651‑2180, Japan. FAU - Nakayama, Hiroto AU - Nakayama H AD - Research and Development Center, Nagaoka Perfumery Co., Ltd., Ibaraki, Osaka 567-0005, Japan. FAU - Miyazato, Hironari AU - Miyazato H AD - Research and Development Center, Nagaoka Perfumery Co., Ltd., Ibaraki, Osaka 567-0005, Japan. FAU - Sugimoto, Keiichiro AU - Sugimoto K AD - Research and Development Center, Nagaoka Perfumery Co., Ltd., Ibaraki, Osaka 567-0005, Japan. FAU - Kobayashi, Yuko AU - Kobayashi Y AD - Department of Food and Nutrition, Faculty of Human Life Sciences, Senri Kinran University, Suita, Osaka 565‑0873, Japan. FAU - Jippo, Tomoko AU - Jippo T AD - Department of Food and Nutrition, Faculty of Human Life Sciences, Senri Kinran University, Suita, Osaka 565‑0873, Japan. FAU - Kuramochi, Kouji AU - Kuramochi K AD - Graduate School of Life and Environmental Sciences, Kyoto Prefectural University, Sakyo-ku, Kyoto 606-8522, Japan. FAU - Yoshida, Hiromi AU - Yoshida H AD - Laboratory of Food and Nutritional Sciences, Faculty of Nutrition, Kobe Gakuin University, Kobe, Hyogo 651‑2180, Japan. FAU - Mizushina, Yoshiyuki AU - Mizushina Y AD - Laboratory of Food and Nutritional Sciences, Faculty of Nutrition, Kobe Gakuin University, Kobe, Hyogo 651‑2180, Japan. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140331 PL - Greece TA - Int J Mol Med JT - International journal of molecular medicine JID - 9810955 RN - 0 (Anti-Inflammatory Agents) RN - 0 (Oils, Volatile) RN - 0 (Tumor Necrosis Factor-alpha) RN - 37341-29-0 (Immunoglobulin E) RN - 37H9VM9WZL (Calcimycin) SB - IM MH - Animals MH - Anti-Inflammatory Agents/*therapeutic use MH - Calcimycin/pharmacology MH - Cell Line, Tumor MH - Citrus/*chemistry MH - Cymbopogon/*chemistry MH - Immunoglobulin E/metabolism MH - Inflammation/drug therapy MH - Mice MH - Oils, Volatile/*therapeutic use MH - Tumor Necrosis Factor-alpha/metabolism EDAT- 2014/04/01 06:00 MHDA- 2014/12/19 06:00 CRDT- 2014/04/01 06:00 PHST- 2013/10/21 00:00 [received] PHST- 2014/02/07 00:00 [accepted] PHST- 2014/04/01 06:00 [entrez] PHST- 2014/04/01 06:00 [pubmed] PHST- 2014/12/19 06:00 [medline] AID - 10.3892/ijmm.2014.1720 [doi] PST - ppublish SO - Int J Mol Med. 2014 Jun;33(6):1643-51. doi: 10.3892/ijmm.2014.1720. Epub 2014 Mar 31.